Get the Daily Brief
Latest Biotech News
Groundbreaking Pig-to-Human Lung Transplant: A Xenotransplantation Milestone
Chinese scientists successfully transplanted a genetically modified pig lung into a brain-dead human recipient, maintaining organ viability for nine days without immediate rejection. This...
Advancements in Immunotherapy Targeting Renal Cell Carcinoma
UCLA researchers report promising preclinical results for Allo CAR70-NKT, an off-the-shelf allogeneic cell therapy engineered to deliver a multipronged attack against metastatic renal cell...
Novel Molecular Mechanisms and Therapeutic Targets in Cancer Biology
Emerging research elucidates key molecular pathways driving cancer progression and resistance. Studies reveal CX26 stabilizes oncogenic c-Myc in pancreatic cancer, enhancing tumor aggressiveness....
Advances in AI-Driven Biomedical Education and Tools
Generative AI is increasingly integrated into biomedical engineering education and drug discovery platforms, enhancing critical thinking and accelerating therapeutic development. Innovative...
FDA narrows COVID booster approvals amid CDC leadership crisis
The U.S. Food and Drug Administration has approved updated COVID-19 booster vaccines targeted at a prevalent subvariant but limited eligibility to older adults and those with underlying...
AI accelerates cancer diagnostics and drug discovery platforms
Artificial intelligence (AI) continues to transform biotechnology with innovations in diagnostics and therapeutic discovery. The expansion of multiomics biomarker detection platforms, such as...
Off-the-shelf immunotherapies show promise in solid tumor models
Innovative off-the-shelf immunotherapies are advancing towards clinical application in cancer treatment. UCLA researchers have engineered AlloCAR70-NKT cells, allogeneic immune effectors designed...
Gut-brain axis immune dynamics and Alzheimer’s disease insights
Emerging research elucidates the intricate immunological crosstalk between the gut and brain in Alzheimer’s disease (AD). Studies using the 5XFAD amyloid-β mouse model reveal altered immune cell...
Novo Nordisk's RNA partnerships expand cardiometabolic therapeutics pipeline
Novo Nordisk has embarked on significant collaborations aimed at enhancing its pipeline for cardiometabolic disorders. The largest involves a multi-year research collaboration with Replicate...
Regulatory and legal developments in oncology diagnostics
Legal and regulatory landscapes continue to shape oncology diagnostic markets. A recent court ruling invalidated two patents asserted by Natera over NeoGenomics’ Radar ST minimal residual disease...
Breakthrough protein engineering platform democratizes design capabilities
A revolutionary open-source platform named BindCraft, created at the École Polytechnique Fédérale de Lausanne (EPFL), is disrupting protein design by enabling the creation of highly specific...
Advances in quantum and photonics technology for communication and computing
In a series of pioneering studies, researchers are propelling the frontier of quantum physics and photonics. Key breakthroughs include the transmission of quantum signals using standard internet...
Transformative stem cell and organ engineering for transplantation and disease models
Recent advancements in regenerative medicine spotlight the engineering of functional tissues and sophisticated cellular models. Kumamoto University scientists have successfully generated...
FDA Narrows COVID-19 Vaccine Use… Leadership Turmoil at CDC
The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines targeting recently circulating strains but restricted eligibility to adults aged 65 and older and individuals...
Novo Nordisk’s $550M RNA Deal Targets Metabolic Disease
Novo Nordisk has entered a multiyear research collaboration with biotech startup Replicate Bioscience, focusing on self-replicating RNA (srRNA) technology to develop novel therapies for obesity,...
AI and Generative Models Advance mRNA Therapeutics at Raina Biosciences
Raina Biosciences has unveiled data from its generative AI platform, GEMORNA, in a study published in Science. GEMORNA leverages transformer-based deep generative models tailored to messenger RNA...
BeOne Medicines Advances Rare Lymphoma Therapy with Sonrotoclax
BeOne Medicines reported positive topline Phase 1/2 data for sonrotoclax, a BCL2 inhibitor targeting mantle cell lymphoma, an aggressive blood cancer subtype. The candidate met the primary...
AI Innovations Transform Clinical and Diagnostic Landscapes
Multiple studies highlight the integration of artificial intelligence (AI) in healthcare and biomedical fields. Cleveland Clinic partnered with Dyania Health to accelerate clinical trial...
New Biotechnologies in Organ Transplant and Regenerative Medicine
Recent advances target improving organ transplant outcomes and regenerative therapies. A platform for scalable production of induced mesenchymal stem cell extracellular vesicles (EVs) promises...
Breakthroughs in Cancer Research and Therapeutics
Multiple oncology breakthroughs underscore progress in cancer diagnostics and treatment. A study identifies prognostic liquid biopsy biomarkers in skin cancer, enhancing precision medicine...